Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

1.15
Delayed Data
As of 10:31am ET
 +0.113 / +10.87%
Today’s Change
0.86
Today|||52-Week Range
5.27
-22.62%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close1.04
Today’s open1.10
Day’s range1.06 - 1.18
Volume30,480
Average volume (3 months)62,200
Market cap$20.2M
Dividend yield--
Data as of 10:31am ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)+13.03%
Earnings growth (this year)+16.91%
Earnings growth (next 5 years)--
Revenue growth (last year)-88.38%
P/E ratioNM
Price/Sales4.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...+0.06+2.09%
OPXAOpexa Therapeutics I...0.000.00%
RTGNRuthigen Inc0.000.00%
PRPHProPhase Labs Inc-0.06-4.29%
Data as of 10:30am ET, 05/26/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$5.6M
Annual profit (last year)-$36.7M
Net profit margin-660.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas Braxton King
Chief Operations Officer &
Executive VP-Operations
Robert A. Lippe
Corporate headquarters
Mountain View, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers